Personal profile
Biography
Dr. Adam C. Kennedy is the Postdoctoral Research Fellow at the ARC Development of Advanced Radiochemical Technologies (DART) Industrial Transformation Training Centre located at Monash University. Adam completed his PhD (2023, Monash University) and has since undertaken a Postdoctoral research position in development of novel chelators and peptides for radioimmunotherapy at Helmholtz-Zentrum Dresden-Rossendorf (HZDR, Dresden, Germany).
His research interests centre around developing peptides and peptidomimetics for radiochemical applications, improving bioconjugation strategies of bifunctional chelators to peptides and biologics, and is leading research in novel metal-peptides complexes.
Research area keywords
- Medicinal Chemistry
- Radiochemistry
- Peptides and Peptidomimetics
- Radioimmunotherapy
- Radiotheranostic Tracers
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 14 Life Below Water
-
α-Conotoxin Peptidomimetics: Probing the Minimal Binding Motif for Effective Analgesia
Kennedy, A. C., Belgi, A., Husselbee, B. W., Spanswick, D., Norton, R. S. & Robinson, A. J., 6 Aug 2020, In: Toxins. 12, 8, 25 p., 505.Research output: Contribution to journal › Review Article › Research › peer-review
Open AccessFile21 Citations (Scopus) -
Probing the propensity of perchlorate anions for surface solvation by infrared photodissociation spectroscopy
Kelly, J. T., Mayer, M., Kennedy, A. C., Schemel, C. & Asmis, K. R., 14 Jun 2018, In: The Journal of Chemical Physics. 148, 22, 8 p., 222840.Research output: Contribution to journal › Article › Research › peer-review
Open Access9 Citations (Scopus)